Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR

Regulations by 2FIRSTS.ai
Jun.13.2024
Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
US Senators criticize health officials for failing to tackle illegal e-cigarette issue, calling for stricter enforcement in hearing.

According to a report from the Associated Press on June 12th, during a hearing held by the Senate Judiciary Committee in the United States on Wednesday, senators harshly criticized senior officials from the health and law enforcement departments for their failure to effectively combat the problem of illegal e-cigarettes in the United States, in an effort to combat the epidemic of youth e-cigarette use.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Chairman of the Senate Judiciary Committee and Illinois Democrat Dick Durbin. | Source: Associated Press

 

The hearing will be chaired by Senator Dick Durbin, who has long been opposed to e-cigarette products. During the hearing, Democratic and Republican members of the Senate Judiciary Committee expressed their frustration and anger at officials from the Food and Drug Administration (FDA) and the Department of Justice for their efforts to regulate the vaping industry.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Translation: FDA Center for Tobacco Products Director Brian King | Image Source: Associated Press

 

Among them, e-cigarette brands like ELFBAR have become the most popular choice among American youth who use e-cigarettes.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Republican Senator Thom Tillis | Image source: Associated Press

 

Senate Judiciary Committee Chairman and Illinois Democrat Dick Durbin stated,

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR
Texas Senator John Cornyn | Image source: Associated Press

 

I just don't understand how the FDA and Justice Department allow thousands of products to remain on store shelves, even when manufacturers have not obtained authorization and in some cases have not even submitted applications.

Senate Hearing: US Officials Criticized for Inadequate E-Cigarette Regulation, Including ELFBAR

 

He referenced a photo of a colorful inventory of e-cigarettes, including Dragon Fruit and Watermelon Bubblegum flavors, sold at a store near the FDA headquarters in Silver Spring, Maryland.

 

These illegal products, based on their taste, are clearly designed for children, yet are being sold under the shadow of the FDA building. How can such a thing be allowed to happen?

 

You have completely failed to fulfill your responsibilities.

 

Deputy Bureau Chief Brian King of the FDA Tobacco Products Center told DeBine.

 

Brian King defended this by stating that the FDA has issued warning letters and civil fines to manufacturers and retailers, and has collaborated with other agencies such as consumers and border protection to seize illegal products. In addition, the approval process has slowed down as a result of a backlog of applications for approval submitted by e-cigarette companies, and regulatory agencies have a legal obligation to review these applications.

 

Due to the large quantity of the product, we must take time to conduct a scientific and legal review of 27 million applications.

 

The FDA has approved a few e-cigarettes as alternatives for adult smokers. All other products on the market, including major sellers like Juul, are awaiting review or are considered illegal by regulatory agencies. A industry lobbyist told the committee that the FDA has rejected over 99% of companies' applications, leading to an unsustainable market situation.

 

The FDA and Department of Justice have banned approximately six e-cigarette companies from selling products that appeal to minors, but more manufacturers continue to release new products, particularly disposable e-cigarettes.

 

Assistant Attorney General Arun Rao informed the Senator that regulators at the Department of Justice and other agencies have deemed the issue of e-cigarettes a "top priority" across the entire administration. In response, Senator Durbin stated, "I don't want empty words, I want action.

 

On Monday (10th), the FDA and the Department of Justice announced the establishment of a new task force to combat illegal e-cigarette sales.

 

Republican Senator Thom Tillis referred to the timing of the notice as a "political stunt" and criticized other federal agencies for not participating in the initiative, including Customs and Border Protection.

 

If the time it takes to establish a special working group is not enough to show how seriously FDA is about cracking down on the proliferation of illegal e-cigarettes, then excluding the U.S. Customs and Border Protection from the special working group will further illustrate this point.

 

He urged officials to focus law enforcement efforts on Chinese brands rather than large American manufacturers like Reynolds Tobacco.

 

According to retail sales data analyzed by Goldman Sachs, the two top-selling disposable products - Breeze and ELFBAR, had sales exceeding $500 million last year. Despite both brands being regulated by the FDA, they continue to be widely sold in the market, with some brands even rebranding with new names, logos, and flavors. Last year, over half of the 2.8 million American youth and young adults who use e-cigarettes reported using ELFBAR.

 

Brian Kim pointed out that products like ELFBAR cannot be legally sold in China, as the Chinese government has already banned non-tobacco flavored e-cigarettes.

 

In response, Texas Senator John Cornyn has vowed to introduce legislation to address what he describes as an "outrageous and unacceptable situation.

 

Click on the text or image to read: ELFBAR's new product AF5000 accused of circumventing UK e-cigarette regulations, EU issues "danger warning" to member states.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Malaysian Tobacco Control Groups Call for Annual 5% Tobacco Tax Hike
Malaysian Tobacco Control Groups Call for Annual 5% Tobacco Tax Hike
According to The Star and The Edge Malaysia, tobacco control groups in Malaysia have urged the government to raise tobacco taxes by at least 5% annually, saying the measure could reduce smoking rates and fund public health and social programmes.
News
May.26
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
U.S. Military Nicotine Policy Sparks Debate as Nicotine Pouches Enter Discussion
An opinion article published by Stars and Stripes argued that the Pentagon’s January nicotine clinical guidelines overemphasize abstinence, fail to reflect the reality that about 30% of active-duty personnel use nicotine, and do not address nicotine pouches as potential harm-reduction products.
Industry Insight
Jun.08
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares Discloses 2025 Annual and Q1 2026 Results With Revenue Growth, Profit Pressure and Expanding New Tobacco Business
Jinjia Shares’ 2025 annual report summary and first-quarter 2026 report show that the company recorded 2025 revenue of RMB 2.988 billion, up 4.57% year on year, while net profit attributable to shareholders turned to a loss of RMB 346 million. In the first quarter of 2026, revenue rose 58.13% year on year to RMB 1.005 billion, but attributable net profit fell 45.16% to RMB 36.5349 million. The company said both revenue and cost growth were related to the expansion of its new tobacco business.
Apr.28 by 2FIRSTS.ai
EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
EU Novel Tobacco Regulation Trends and Business Response | Guest Contribution by a European Legal and Compliance Expert
Carlos Cabrera, founder of CabLab Law & Advocacy, contributes this article to 2Firsts, arguing that the EU’s evolving approach to novel tobacco regulation may unintentionally reinforce cigarette use by narrowing alternatives. He warns companies to watch signals on flavours, labelling, traceability, nicotine pouch rules and digital marketing, while grounding business decisions in realistic timelines, compliance planning and continuous monitoring.
Apr.22